REACHING CONTINUOUS GLUCOSE MONITORING TARGETS WITH SENSOR-AUGMENTED PUMP: A CASE REPORT
Journal
DIABETES TECHNOLOGY & THERAPEUTICS
Date Issued
2023-02
Author(s)
DOI
10.1089/dia.2023.2525.abstracts
Abstract
Background and Aims
Sensor-augmented pumps with predictive low-glucose suspend (SAP with PLGS) can be a good therapy option in
countries where hybrid closed loop systems are not available.
We present a case of a 25 year old patient with history of uncontrolled diabetes achieving CGM targets using SAP
with PLGS (Medtronic Minimed 640G, Guardian Sensor 3).
Methods
Female patient diagnosed with type 1 diabetes at the age of 8, had a history of uncontrolled diabetes with MDI
therapy. Despite optimizing parameters of flexible MDI her A1C during the last 6 years has been between 9.0-9.7%.
Intermittent use of professional CGM confirmed high glucose variation and high average sensor glucose. Before
initiating SAP her TDD was 54 units (0.8 u/kg), ICR 6 grams/U, ISF 2.0 mmol/L/U and glucose target 6.5mmol/l.
After 5 days of 2 hours education SAP was initiated. CGM analysis was performed regularly on day 1, 3, 7 the first
week of initiation and every 2 weeks thereafter using Medtronic CarelinkTM System Software. Fine tuning of
settings was made during the online visits according to CGM parameters and weight reduction leading to TDD of
32U (0.6U/kg). In person visits were performed the 1st
and 3rd month.
Results
After 90 consecutive days of sensor wear we achieved the following CGM metrics: 78% Time In Range, 3+1 % Time
Below Range, 16+2 % Time Above Range, Average Sensor Glucose 7.8 mmol/l, Glucose Management Indicator of
6.7% and Coefficient of Variation 32%.
Conclusions
SAP with PLGS can be a helpful tool to achieving good glycemic control in selected patients.
Sensor-augmented pumps with predictive low-glucose suspend (SAP with PLGS) can be a good therapy option in
countries where hybrid closed loop systems are not available.
We present a case of a 25 year old patient with history of uncontrolled diabetes achieving CGM targets using SAP
with PLGS (Medtronic Minimed 640G, Guardian Sensor 3).
Methods
Female patient diagnosed with type 1 diabetes at the age of 8, had a history of uncontrolled diabetes with MDI
therapy. Despite optimizing parameters of flexible MDI her A1C during the last 6 years has been between 9.0-9.7%.
Intermittent use of professional CGM confirmed high glucose variation and high average sensor glucose. Before
initiating SAP her TDD was 54 units (0.8 u/kg), ICR 6 grams/U, ISF 2.0 mmol/L/U and glucose target 6.5mmol/l.
After 5 days of 2 hours education SAP was initiated. CGM analysis was performed regularly on day 1, 3, 7 the first
week of initiation and every 2 weeks thereafter using Medtronic CarelinkTM System Software. Fine tuning of
settings was made during the online visits according to CGM parameters and weight reduction leading to TDD of
32U (0.6U/kg). In person visits were performed the 1st
and 3rd month.
Results
After 90 consecutive days of sensor wear we achieved the following CGM metrics: 78% Time In Range, 3+1 % Time
Below Range, 16+2 % Time Above Range, Average Sensor Glucose 7.8 mmol/l, Glucose Management Indicator of
6.7% and Coefficient of Variation 32%.
Conclusions
SAP with PLGS can be a helpful tool to achieving good glycemic control in selected patients.
File(s)![Thumbnail Image]()
![Thumbnail Image]()
Loading...
Name
ATTD2023.png
Size
92.96 KB
Format
PNG
Checksum
(MD5):f1df1ae07b0eaa0b406032880c0f0579
Loading...
Name
ATTD2023 (2).png
Size
57.02 KB
Format
PNG
Checksum
(MD5):c3134f91a1e7b2ddb02f19daad5b7985